38
Participants
Start Date
June 30, 2020
Primary Completion Date
March 10, 2021
Study Completion Date
March 10, 2021
Drug: GC4419
GC4419 60 Minute Infusion
Intensity-modulated radiation therapy (IMRT)
2.0 to 2.2 Gy daily over 7 weeks
Cisplatin
100mg/m2 once every 3 weeks or 40mg/m2 once weekly for 6-7 doses
Onze-Lieve-Vrouwziekenhuis (OLVZ) - Campus Aalst, Aalst
AZ Klina, Brasschaat
Az Nikolaas, Sint-Niklaas
CHR Verviers, Verviers
Fakultni Nemocnice Na Bulovce, Prague
University Medical Center Schleswig-Holstein, Kiel
Universitatsklinikum Leipzig AoR, Leipzig
Centrum Onkologii im. Prof. F. Lukaszczyka w Bydgoszczy, Bydgoszcz
Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie, Krakow
Szpitale Pomorskie Sp. z o.o., Pomorskie
Cancer Center Institute of Oncology, Warsaw
Complejo Hospitalario Universitario De Santiago De Compostela, A Coruña
Gurutzetako Unibersitate Ospitalea - Hospital Universitario Cruces - Instituto BioCruces, Barakaldo
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Universitario de Fuenlabrada, Fuenlabrada
Institut Catala d'Oncologia de Girona, Girona
Complejo Hospitalario de Jaen, Jaén
Hospital Madrid Universitario Sanchinarro (Centro Integral Oncologico Clara Campal), Madrid
Hospital Universitario Ramon y Cajal, Madrid
Complejo Hospitalario de Navarra (CHN), Pamplona
Hospital universitario Virgen del Rocio, Salamanca
Universidad de Salamanca - Hospital Clinico Universitario, Salamanca
University Hospital Basel, Basel
University Hospital of Bern, Inselspital, Fribourg
Lead Sponsor
Galera Therapeutics, Inc.
INDUSTRY